Ekine

Company Overview

Snapshot

Founded in March 2023 by Yael Policker, Ekine operates with 1–10 employees. The company received a grant from the Israel Innovation Authority in January 2024.

Business overview

Ekine develops plant-based fertility control products designed to manage animal reproduction in urban environments. Its solution offers a non-invasive, reversible, and cost-effective alternative to traditional sterilization, aiming to prevent uncontrolled propagation in both domestic and public settings. Formulated for ease of use without requiring prescriptions or professional administration, the treatment supports humane population control while maintaining animal welfare. Ekine's approach enables scalable implementation across wide animal populations, promoting coexistence between humans, animals, and the urban ecosystem within the Agriculture & Food Technologies sector.

Company Intelligence Q&A

What is Ekine's primary focus?

Ekine focuses on developing plant-based fertility control solutions for animal reproduction management in urban environments, offering a non-invasive and cost-effective alternative to traditional sterilization.

When was Ekine founded?

Ekine was founded in March 2023.

Who is the founder of Ekine?

Yael Policker is the founder of Ekine.

What is the current status of Ekine?

Ekine is currently non-active and ceased to operate in May 2026.